Understanding Cancer

Barriers to CAR T-Cell Therapy: Cost and Clinical Effectiveness

Use of CAR T-cell therapy remains limited, partly due to barriers in cost and clinical effectiveness. Learn more.

Despite the New CDC Guidance, Should I Still Wear a Mask?

Although lightened CDC guidelines have been announced, those who are immunocompromised may still need to err on the side of caution. Read more.

Latest News

Medicaid Eligibility Income Limits Affect Cancer Outcomes

Ask the Expert: What Are Antibodies?

Andrew Schorr, Esther Schorr, James (Jim) Griffith, PhD, CLS (NCA) , Susan Leclair, PhD, CLS (NCA)

Experts Weigh In on Booster Shots for the Immunocompromised

Andrew Schorr, Esther Schorr, James (Jim) Griffith, PhD, CLS (NCA) , Susan Leclair, PhD, CLS (NCA)

CDC Recommends Third COVID-19 Vaccine Dose for Immunocompromised Patients

As a Cancer Patient, Will I Need an Extra Dose of a COVID-19 Vaccine?

One Letter Makes a Difference: Avoiding Online Research Pitfalls

How to Talk to Friends and Family About Vaccination

Immunotherapy Drug Combination Shows Promise in Melanoma

Pride 2021: Making Cancer Care More Accessible for Everyone

As COVID-19 Restrictions Are Lifted, How Safe Are People With Cancer?

Delays in Cancer Screening and Care During the Pandemic

If I Have Cancer, What Is My Risk for COVID-19?